Researchers Show Probiotics are a Promising Treatment for NEC

August 12, 2009 By Darci Slaten

(PhysOrg.com) -- Researchers have determined that using probiotics, or healthy live bacteria, is an effective method to reduce and prevent a gastrointestinal disease that predominantly affects premature infants.

Research led by Bohuslav Dvorak, research professor of pediatrics, and anatomy at The University of Arizona's Steele Children's Research Center, has determined that using probiotics, or healthy live bacteria, is an effective method to reduce and prevent necrotizing enterocolitis, known as NEC.

NEC is a gastrointestinal disease that predominantly affects premature infants. Every year, approximately 10,000 are afflicted with NEC. The disease can be mild to severe with mortality rates around 40 percent.

In severe cases, a child's inflamed intestines may tear or perforate, allowing bacteria from intestines to leak into the abdomen, potentially causing a life-threatening systemic infection. The exact cause of NEC is unknown and there are no effective treatments for this disease.

Initial clinical studies suggest that supplementation of infant formula with probiotics is beneficial in the prevention of NEC. However, there are still considerable concerns among physicians about the safety of feeding live bacteria to prematurely born babies.

Using an experimental model of NEC, Dvorak and his team have recently shown that oral administration of probiotics is a promising strategy for prevention of NEC. "Our studies confirmed that the probiotic Bifidobacterium bifidum, when added to formula, significantly reduces the incidence and severity of NEC," said Dvorak. "We found that this particular strain of probiotics reduces inflammation in the intestines and reinforces the intestinal barrier."

"Now that we've determined the efficacy of Bifidobacterium bifidum, we are exploring the safety of probiotics, how probiotics protect against NEC at the cellular and molecular levels, and what long-term consequences - if any - they have on immune and gastrointestinal functions," he said.

Provided by University of Arizona (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (1 vote)


August 12, 2009 all stories

Comments: 0

5 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

Engineers, doctors develop novel material that could help fight arterial disease

Medicine & Health / Research

created 22 minutes ago | popularity not rated yet | comments 0

A fortuitous discovery that grew out of a collaboration between UCLA engineers and physicians could potentially offer hope to the nearly 10 million Americans who suffer from peripheral arterial disease.


Some patients diagnosed with HIV experience improved outlook on life

Medicine & Health / HIV & AIDS

created 12 minutes ago | popularity not rated yet | comments 0

A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their ...


Physicians Explore Link Between Vitamin D Deficiency and Hypertension

Physicians Explore Link Between Vitamin D Deficiency and Hypertension

Medicine & Health / Health

created 44 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Drs. William White and Pooja Luthra at the University of Connecticut Health Center are investigating a possible link between vitamin D deficiency and high blood pressure.


Brain's endocannabinoid signaling pathway kept in check by two enzymes

Medicine & Health / Research

created 1hour ago | popularity 5 / 5 (1) | comments 0

(PhysOrg.com) -- A research team has shown that blocking the degradation of two naturally occurring cannabinoids in the endocannabinoid signaling pathway of the brain produces marijuana-like behavioral effects in mice, according ...


Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 3 hours ago | popularity 5 / 5 (5) | comments 0

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...